Form 4 for NSPR InspireMD, Inc.
Accepted 2026-01-16 00:00:00 ET · period of report 2026-01-14 · accession 0001493152-26-002665 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-16 | 2026-01-14 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +453.4K | 1.20M | +61% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-14 | A | A | 453,390 | $0.00 | 1,200,371 | D | — | — | (F1) These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service. |